Simplex Trading’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-17,000
| Closed | -$60K | – | 11875 |
|
|
2021
Q4 | $60K | Buy |
17,000
+16,400
| +2,733% | +$57.4K | ﹤0.01% | 7023 |
|
|
2021
Q3 | $2K | Buy |
+600
| New | +$2.43K | ﹤0.01% | 9603 |
|
|
2021
Q2 | – | Sell |
-320
| Closed | -$131K | – | 10989 |
|
|
2021
Q1 | $131K | Sell |
320
-87
| -21% | -$377 | ﹤0.01% | 5374 |
|
|
2020
Q4 | $162K | Sell |
407
-22
| -5% | -$71 | ﹤0.01% | 4890 |
|
|
2020
Q3 | $115K | Buy |
429
+54
| +14% | +$149 | ﹤0.01% | 4754 |
|
|
2020
Q2 | $103K | Buy |
375
+57
| +18% | +$159 | ﹤0.01% | 4761 |
|
|
2020
Q1 | $75K | Buy |
318
+104
| +49% | +$354 | ﹤0.01% | 4695 |
|
|
2019
Q4 | $100K | Buy |
214
+95
| +80% | +$389 | ﹤0.01% | 4518 |
|
|
2019
Q3 | $39K | Sell |
119
-188
| -61% | -$619 | ﹤0.01% | 5262 |
|
|
2019
Q2 | $101K | Sell |
307
-137
| -31% | -$396 | ﹤0.01% | 4185 |
|
|
2019
Q1 | $134K | Buy |
444
+411
| +1,245% | +$1.33K | ﹤0.01% | 4041 |
|
|
2018
Q4 | $8K | Sell |
33
-40
| -55% | -$132 | ﹤0.01% | 6015 |
|
|
2018
Q3 | $24K | Buy |
73
+20
| +38% | +$62 | ﹤0.01% | 5823 |
|
|
2018
Q2 | $13K | Buy |
+53
| New | +$132 | ﹤0.01% | 6195 |
|
|
2017
Q3 | – | Sell |
-95
| Closed | -$2K | – | 6905 |
|
|
2017
Q2 | $2K | Buy |
95
+7
| +8% | +$20 | ﹤0.01% | 5405 |
|
|
2017
Q1 | $2K | Sell |
88
-301
| -77% | -$724 | ﹤0.01% | 5413 |
|
|
2016
Q4 | $8K | Buy |
389
+42
| +12% | +$80 | ﹤0.01% | 3979 |
|
|
2016
Q3 | $5K | Buy |
+347
| New | +$425 | ﹤0.01% | 4355 |
|
Other funds holding ATRS
Simplex Trading's ATRS Position: Q2 2022 in Review
Simplex Trading sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 25,514 shares — an estimated $104K sold.
Simplex Trading first reported a position in ATRS in Q3 2015 and held it in 20 quarters. The position peaked at $295K in Q2 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Simplex Trading reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Simplex Trading sold 25,514 Antares Pharma, Inc. shares in Q2 2022, an estimated $104K.
- Simplex Trading first reported a position in Antares Pharma, Inc. in Q3 2015 and held it in 20 quarters.
- Simplex Trading's Antares Pharma, Inc. position peaked at $295K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.